DOWNLOAD FOR iPHONE®,
iPOD TOUCH®, AND iPAD®
DOWNLOAD FOR ANDROIDTM
Repurposed by permission from Elsevier Inc.
Adapted from the report by the American College of Cardiology Foundation, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.
Please note: The content or material provided herein is for informational purposes only and should not be construed as medical, legal, financial, investment, or other professional advice or opinion. This application, and the included Framingham Risk Score calculator, is not intended for the diagnosis of disease or other conditions, or the cure, mitigation, treatment, or prevention of disease.
This application is intended to help guide you through the process of deciding whether cardiac RNI is potentially appropriate for your patient, based on the appropriate use criteria (AUC) developed by the authors of the publication on which this application is based. By entering information about your patient, you will determine on a scale of 1 to 9 if they meet the criteria of appropriate use. Although these criteria may provide guidance for patients and clinicians, they are not intended to serve as substitutes for sound clinical judgment and practice experience.
1. Hendel RC, et al. J Am Coll Cardiol. 2009;53:2201-2229.
iPhone, iPod Touch and iPad are legal trademarks of Apple Inc, registered in the U.S. and other countries.
Android is a trademark of Google Inc. Use of this trademark is subject to Google Permissions.